Skip to main content

Menu Close

Help and support

Help and support

FAQ's
Glossary

FAQ's

How is the safety of a new gene therapy determined?

How are gene and cell therapies different to 'traditional' therapies?

Where do embryonic stem cells for research come from?

How is the production of gene and cell therapies different to traditional treatments?

Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?

What is genetic testing?

Is it ethical to use animals in health and scientific research?

What are the roles of regulators in the development of gene and cell therapies?

Glossary

Accelerated assessment

Adeno-associated virus (AAV)

Adult stem cells

Advanced Therapy Investigational Medicinal Product (ATIMP)

Advanced Therapy Medicinal Product (ATMP)

See full Glossary

Search

Select language

Select language

English
Français
Deutsch
Italiano
Polski
Español
Português

Select language

Select language

English
Français
Deutsch
Italiano
Polski
Español
Português

Condition

Muscle and Skeletal Diseases
Blood Disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Immune Deficiency
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility

Theme

Cell and Gene Fundamentals
Blood Stem Cells
Genes and Inheritance
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments

Main navigation

Discover
Research Pathways
About Us
Contact

Breadcrumb

ATMP Engage
PPI Directory
Patient Engagement

Patient Engagement

See page 5 for key issues in patient engagement.

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts

Footer menu

Terms & Conditions
Privacy
Accessibility
Contact Us

EuroGCT on Facebook EuroGCT on LinkedIn EuroGCT on BlueSky

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 965241.

© Copyright 2020-2025 EuroGCT and contributing authors